OrSense (Israel) a commercial-stage medical device company focused on non-invasive measurements of oxygen saturation, hemoglobin, glucose and other blood parameters, closed $18M Series D financing. Participants include Israel HealthCare Ventures, Star Ventures and Lewis Trust Private Equity.